Precision of AI-Based Cardiac Ultrasound for LVEF in the Elderly

NCT ID: NCT06478901

Last Updated: 2024-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

129 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-14

Study Completion Date

2024-02-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Heart failure (HF) is common in older adults, especially those over 65. It is a leading cause of hospitalization and has high mortality rates. Diagnosing HF in elderly patients can be challenging due to atypical symptoms and multiple other health issues. Echocardiography, an ultrasound of the heart, is crucial for accurate diagnosis and treatment planning.

One problem in geriatric care is the difficulty of accessing echocardiography due to high demand and limited specialized doctors. Recent advancements show that AI-assisted portable ultrasound devices can reliably measure heart function, producing results comparable to traditional methods.

This study aims to evaluate the accuracy and relevance of AI-assisted echocardiography (AutoEF-AI) in elderly patients. It also assesses whether geriatricians, even without specialized training, can capture quality images for AI analysis.

In simple terms, this study investigates if portable ultrasound devices with AI can provide precise heart function diagnostics, making it easier for older adults with heart failure to get the care they need, even without specialists.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Heart failure (HF) is a major chronic illness, particularly common in older adults. With advances in healthcare and an aging population, HF is increasingly affecting people over 65 years old. In fact, 80% of HF patients are over 65. HF is associated with high mortality rates and is the leading cause of hospitalization after age 80, and even after age 65 in some countries like France.

In older adults, HF symptoms are often atypical due to multiple other health conditions, increased frailty, and associated geriatric syndromes, making diagnosis difficult. In this context, echocardiography (an ultrasound of the heart) is essential for accurately diagnosing HF.

Evaluating the left ventricular ejection fraction (LVEF) through echocardiography is a fundamental step in diagnosing HF and deciding on treatment strategies. This evaluation helps refine the HF diagnosis, propose appropriate treatments, and monitor changes in heart function over time.

One major challenge in geriatric units and nursing homes (EHPADs) is the difficulty in accessing echocardiography due to growing demand and a limited number of specialized doctors.

Recent studies have shown that automated LVEF measurements assisted by artificial intelligence (AI) using portable ultrasound devices are reliable and produce results comparable to traditional methods. This AI-assisted automatic LVEF calculation (AutoEF-AI) could be a major advantage in geriatric departments, providing a credible alternative to conventional echocardiography for evaluating LVEF in HF patients.

The main goal of this study was to evaluate the relevance and accuracy of AutoEF-AI echocardiography in elderly patients. The secondary goal was to assess whether geriatricians without specialized training in echocardiography could capture images of sufficient quality to be analyzed by automatic LVEF algorithms with acceptable accuracy.

In simple terms, this study aims to determine if using portable ultrasound devices, assisted by artificial intelligence, can provide diagnostics as precise as traditional methods. This could make evaluating heart function more accessible and effective for older adults with heart failure, even when specialists are not available.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Heart Failure Systolic Elderly Artificial Intelligence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Echocardiography

Echocardiography assited by Artificial intelligence

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 75 years and a clinical presentation of acute heart failure consistent with the criteria of the European Society of Cardiology guidelines

Exclusion Criteria

* unstable patient
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hôpital Broca APHP

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Broca

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Chaudhry SI, Wang Y, Gill TM, Krumholz HM. Geriatric conditions and subsequent mortality in older patients with heart failure. J Am Coll Cardiol. 2010 Jan 26;55(4):309-16. doi: 10.1016/j.jacc.2009.07.066.

Reference Type RESULT
PMID: 20117435 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRECIS-AI-2024-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HeartGuide: Preliminary Study
NCT05490303 UNKNOWN NA